![Humira Rivals Set to Try to Drive Down Cost of Blockbuster Drug](https://getmga.com/wp-content/uploads/2023/02/iStock-1177433803-1080x675.jpg)
Humira Rivals Set to Try to Drive Down Cost of Blockbuster Drug
“Given the long-term success of Humira, which can cost patients up to $84,000 a year, initial uptake of the biosimilars may be limited, said Alex Brill, founder and CEO of economic policy consulting firm Matrix Global Advisors.”